Related references
Note: Only part of the references are listed.Neuroendocrine Tumors of Midgut and Hindgut Origin: Tumor-Node-Metastasis Classification Determines Clinical Outcome
Henning Jann et al.
CANCER (2011)
Future Directions in the Treatment of Neuroendocrine Tumors: Consensus Report of the National Cancer Institute Neuroendocrine Tumor Clinical Trials Planning Meeting
Matthew H. Kulke et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Metastatic and Locally Advanced Pancreatic Endocrine Carcinomas: Analysis of Factors Associated With Disease Progression
Francesco Panzuto et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors.
Eric Raymond et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Everolimus for Advanced Pancreatic Neuroendocrine Tumors.
James C. Yao et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Carcinoid Tumors of the Gastrointestinal Tract: Trends in Incidence in England Since 1971
Libby Ellis et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
Incidence, patterns of care and prognostic factors for outcome of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): results from the National Cancer Registry of Spain (RGETNE)
R. Garcia-Carbonero et al.
ANNALS OF ONCOLOGY (2010)
Gastroenteropancreatic neuroendocrine tumours: the current incidence and staging based on the WHO and European Neuroendocrine Tumour Society classification: an analysis based on prospectively collected parameters
Martin B. Niederle et al.
ENDOCRINE-RELATED CANCER (2010)
Pancreatic endocrine tumors: improved TNM staging and histopathological grading permit a clinically efficient prognostic stratification of patients
Aldo Scarpa et al.
MODERN PATHOLOGY (2010)
Prognostic factors influencing survival from metastatic (stage IV) gastroenteropancreatic well-differentiated endocrine carcinoma
Cosimo Durante et al.
ENDOCRINE-RELATED CANCER (2009)
Midgut neuroendocrine tumours with liver metastases: results of the UKINETS study
A. Ahmed et al.
ENDOCRINE-RELATED CANCER (2009)
Improved histologic and clinicopathologic criteria for prognostic evaluation of pancreatic endocrine tumors
Stefano La Rosa et al.
HUMAN PATHOLOGY (2009)
Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group
Anja Rinke et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Small intestinal neuroendocrine tumors: Prognostic factors and survival
Deidi Strickland Bergestuen et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2009)
Prognostic factors at diagnosis and value of WHO classification in a mono-institutional series of 180 non-functioning pancreatic endocrine tumours
R. Bettini et al.
ANNALS OF ONCOLOGY (2008)
Prognostic Factors and Survival in 324 Patients with Pancreatic Endocrine Tumor Treated at a Single Institution
Sara Ekeblad et al.
CLINICAL CANCER RESEARCH (2008)
Prognostic factors of long-term outcome in gastroenteropancreatic neuroendocrine tumours
Ulrich-Frank Pape et al.
ENDOCRINE-RELATED CANCER (2008)
One hundred years after Carcinoid: Epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States
James C. Yao et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Gastroenteropancreatic neuroendocrine tumours
Irvin M. Modlin et al.
LANCET ONCOLOGY (2008)
Consensus guidelines for the management of patients with digestive neuroendocrine tumors - Well-differentiated jejunal-ileal tumor/carcinoma
Barbro Eriksson et al.
NEUROENDOCRINOLOGY (2008)
TNM staging of midgut and hindgut (neuro) endocrine tumors:: a consensus proposal including a grading system
G. Rindi et al.
VIRCHOWS ARCHIV (2007)
Operative resection of primary carcinoid neoplasms in patients with liver metastases yields significantly better survival
Babak Givi et al.
SURGERY (2006)
TNM staging of foregut (neuro)endocrine tumors:: a consensus proposal including a grading system
G. Rindi et al.
VIRCHOWS ARCHIV (2006)
Endocrine Tumors of the Ileum: Factors Correlated with Survival
Paola Tomassetti et al.
NEUROENDOCRINOLOGY (2006)
Prognostic factors and survival in endocrine tumor patients: comparison between gastrointestinal and pancreatic localization
F Panzuto et al.
ENDOCRINE-RELATED CANCER (2005)
Octreotide versus octreotide plus interferon-alpha in endocrine gastroenteropancreatic tumors:: A randomized trial
R Arnold et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2005)
A statistical simulation study finds discordance between WHO criteria and RECIST guideline
M Mazumdar et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2004)
The diagnosis and medical management of advanced neuroendocrine tumors
GA Kaltsas et al.
ENDOCRINE REVIEWS (2004)
Prospective, randomized, multicenter trial on the antiproliferative effect of lanreotide, interferon alfa, and their combination for therapy of metastatic neuroendocrine gastroenteropancreatic tumors -: The International Lanreotide and Interferon Alfa Study Group
S Faiss et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Effect of surgery on the outcome of midgut carcinoid disease with lymph node and liver metastases
P Hellman et al.
WORLD JOURNAL OF SURGERY (2002)